« previous next »
Pages: [1]

Author Topic: (JAMA editorial) Addressing the rising prices of DMTs for MS  (Read 173 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9843
  • MS diagnosed 1980
  • Location: Pacific Northwest
(JAMA editorial) Addressing the rising prices of DMTs for MS
« on: August 26, 2019, 04:45:30 pm »
Editorial in JAMA Neurology (August 26, 2019) urging neurologists to do more to contain the skyrocketing cost of the MS drugs--"Addressing the Rising Prices of Disease-Modifying Therapies for Multiple Sclerosis":




http://bit.ly/2ZjzkSu
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
111 Views 		Last post June 04, 2016, 02:03:45 pm
by agate
1 Replies
142 Views 		Last post June 13, 2016, 08:52:26 am
by agate
0 Replies
221 Views 		Last post January 03, 2017, 02:50:23 pm
by agate
0 Replies
194 Views 		Last post October 12, 2017, 06:17:06 pm
by agate
1 Replies
99 Views 		Last post November 15, 2019, 07:49:05 pm
by agate